Halozyme Therapeutics, Inc. (HALO) stock prices updated...
 

Halozyme Therapeutics, Inc. stock price

Halozyme Therapeutics, Inc. latest news:


  • 01/09/2018 16:35:25

    BRIEF-Halozyme Projects 25 To 30 Percent Enhanze Royalty Growth In 2018

    Halozyme Therapeutics Inc(HALO): * HALOZYME PROJECTS 25 TO 30 PERCENT ENHANZE ROYALTY GROWTH IN 2018. * Halozyme Therapeutics Inc(HALO) - ‍ FORECASTS POTENTIAL ROYALTY REVENUE FOR ENHANZE TO REACH NEARLY $1 BILLION IN 2027 ​. * Halozyme Therapeutics Inc (HALO) - ‍EXPECTS ADDITIONAL PARTNERS TO BEGIN THREE PHASE 1 STUDIES WITH NEW TARGETS FOR ENHANZE​ IN 2018 Source text for Eikon: Further company coverage:

  • More trends:

    Hamilton Bancorp, Inc.HBK | Hampton Roads Bankshares IncHMPR | Hancock Holding CompanyHBHC | Hancock Holding CompanyHBHCL | Handy & Harman Ltd.HNH | Hanmi Financial CorporationHAFC | Hansen Medical, Inc.HNSN | Hanwha Q CELLS Co., Ltd. HQCL | Hardinge, Inc.HDNG | Harmonic Inc.HLIT |